Experts predict the controversial tactic will be deployed far more widely this year, significantly impacting manufacturers — and, whether or not they realize it yet, patients.
Predictions for new trends are rooted in healthcare’s complicated history
Collaboration among payers and pharma companies is making a comeback, spurred by a renewed appetite for value-based contracting on medicines. And with a wave of extraordinarily high-priced, curative therapies right around the corner, the pace is about to pick way up.
Marketers on taking advantage of online health community forums
From product design to social experiment to entertainment that turns into a product itself, these big tactical ideas are breaking new ground and challenging us to expand our thinking.
Critics who want to cut drug prices must say which ones
Nearly six years ago, programs that paid KOLs to preach pharma’s gospel to an audience of HCPs seemed on the way out. Today, those same programs are thriving. Here’s how GlaxoSmithKline, by eliminating paid speaking, may have reinvigorated it.
Novo Nordisk’s Anders Dyhr Toft talks health tech and engaging the startup community